What Researchers Did
Researchers retrospectively analyzed 397 patients with glottic cancer, comparing radiotherapy treatment in air versus a hyperbaric oxygen chamber.
What They Found
The study found a significant improvement in local tumor control rates with hyperbaric oxygen (HBO) treatment, showing increases of 10% for Stage I, 37% for Stage II, and 73% for Stage III glottic cancer. This enhanced local control was achieved without an increase in morbidity rates.
What This Means for Canadian Patients
For Canadian patients with glottic cancer, these findings suggest that radiotherapy delivered in a hyperbaric oxygen chamber could significantly improve local tumor control. This improved efficacy appears to be achieved without increasing treatment-related side effects, offering a potentially more effective treatment option.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or with Canadian participants.
Study Limitations
A limitation of this study is its retrospective design, which may be subject to selection bias and confounding factors.